Sanctuary Advisors LLC Has $13.71 Million Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Sanctuary Advisors LLC boosted its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1,164.3% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 34,301 shares of the biotechnology company’s stock after acquiring an additional 31,588 shares during the quarter. Sanctuary Advisors LLC’s holdings in Axon Enterprise were worth $13,707,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Public Sector Pension Investment Board lifted its holdings in shares of Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after buying an additional 500 shares during the last quarter. CIBC Asset Management Inc raised its stake in Axon Enterprise by 9.2% during the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the last quarter. Foundations Investment Advisors LLC bought a new stake in Axon Enterprise in the 3rd quarter valued at $221,000. Sequoia Financial Advisors LLC grew its position in Axon Enterprise by 4.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after purchasing an additional 81 shares during the last quarter. Finally, Axxcess Wealth Management LLC bought a new position in shares of Axon Enterprise during the 3rd quarter worth about $814,000. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Robert W. Baird lifted their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group upped their target price on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. JMP Securities lifted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $488.67.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $644.91 on Friday. The stock has a market capitalization of $49.17 billion, a price-to-earnings ratio of 166.64, a P/E/G ratio of 14.14 and a beta of 1.01. The firm’s 50-day moving average price is $539.52 and its two-hundred day moving average price is $404.63. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $241.72 and a 1-year high of $698.67.

Insider Transactions at Axon Enterprise

In other news, Director Jeri Williams sold 110 shares of the stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $400.00, for a total transaction of $44,000.00. Following the sale, the director now directly owns 1,934 shares of the company’s stock, valued at $773,600. This represents a 5.38 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $380.99, for a total transaction of $380,990.00. Following the completion of the sale, the director now directly owns 27,259 shares of the company’s stock, valued at approximately $10,385,406.41. This represents a 3.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 99,590 shares of company stock valued at $49,176,907 in the last three months. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.